R2 open online free no code data science platform for biomedical researchers no bioinformatics expertise needed
r2platform.com
R2 open online free no code data science platform for biomedical researchers no bioinformatics expertise needed
r2platform.com
Corrado Santocanale & coworkers find it to cooperate with CDC7 in MCM helicase phosphorylation & activation–with implications for antiproliferative actions of CDC7 inhibitors
link.springer.com/article/10.1...
➡️ nature.com/articles/s41...
@mskcancercenter.bsky.social
➡️ nature.com/articles/s41...
@mskcancercenter.bsky.social
Each gene is represented by its text description, so PIE works across the different gene sets measured in different studies.
Each gene is represented by its text description, so PIE works across the different gene sets measured in different studies.
🧬TCGA - www.cancer.gov/ccg/research...
🧬DepMap - depmap.org/portal/
🧬1000 Genomes - www.internationalgenome.org
🧬recount3 - rna.recount.bio
Are there better resources you use for genomics datasets? What am I missing?
🧬TCGA - www.cancer.gov/ccg/research...
🧬DepMap - depmap.org/portal/
🧬1000 Genomes - www.internationalgenome.org
🧬recount3 - rna.recount.bio
Are there better resources you use for genomics datasets? What am I missing?
The math is clear:
Normal diploid: log2(2/2) = 0
Single gain: log2(3/2) = 0.585
Single loss: log2(1/2) = -1.0
High amplification: log2(6/2) = 1.585
But tumor purity complicates everything! read this post on the depmap forum forum.depmap.org/t/defining-...
The math is clear:
Normal diploid: log2(2/2) = 0
Single gain: log2(3/2) = 0.585
Single loss: log2(1/2) = -1.0
High amplification: log2(6/2) = 1.585
But tumor purity complicates everything! read this post on the depmap forum forum.depmap.org/t/defining-...
Register now 👉 humantechnopole.it/en/trainings...
Another use case is making sense of gene lists
Here is one example of how SPARKIT could be used to triage genes from a high-throughput screen sparkit.science/blog/crispr-...
Another use case is making sense of gene lists
Here is one example of how SPARKIT could be used to triage genes from a high-throughput screen sparkit.science/blog/crispr-...
Replication studies in biomedical research are too slow & expensive to scale (e.g. engineered models).
Why not move towards “pseudo-replication” in silico?
Instead of redoing the experiment, test the core claim using independent public datasets (e.g. TCGA, GEO, DepMap).
Replication studies in biomedical research are too slow & expensive to scale (e.g. engineered models).
Why not move towards “pseudo-replication” in silico?
Instead of redoing the experiment, test the core claim using independent public datasets (e.g. TCGA, GEO, DepMap).
Vicky Le. The idea for a "noncoding Cancer DepMap" started with some of my first students, Meer Mustafa and Bianca Diaz. Big shout-out to Meer & Bianca for their early contributions!
Vicky Le. The idea for a "noncoding Cancer DepMap" started with some of my first students, Meer Mustafa and Bianca Diaz. Big shout-out to Meer & Bianca for their early contributions!
depmap.org/portal/
depmap.org/portal/
And these have been wonderfully successful: e.g. Cancer DepMap in 1,000+ human cell lines for protein-coding genes, or the sickle-cell cure CASGEVY discovered in a noncoding CRISPR screen.
And these have been wonderfully successful: e.g. Cancer DepMap in 1,000+ human cell lines for protein-coding genes, or the sickle-cell cure CASGEVY discovered in a noncoding CRISPR screen.
1) Highest co-dependency score in DepMap.
2) Rare germline mutations in both produce overlapping neurodevelopmental disorders.
3) PHIP was recently reported to be mutated in AML (Stiff et al, Nat Gen 2024). (6/n)
1) Highest co-dependency score in DepMap.
2) Rare germline mutations in both produce overlapping neurodevelopmental disorders.
3) PHIP was recently reported to be mutated in AML (Stiff et al, Nat Gen 2024). (6/n)
by Arafeh R, Shibue T (...) Vazquez F et 2 al. in Nat Rev Cancer #MedSky
📖 read the article:
by Arafeh R, Shibue T (...) Vazquez F et 2 al. in Nat Rev Cancer #MedSky
📖 read the article: